Articles |
From the Department of Geriatric Medicine, Faculty of Medicine, Kyoto University, Japan.
Correspondence to Noriaki Kume, MD, PhD, Department of Geriatric Medicine, Faculty of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606, Japan.
Abstract Lysophosphatidylcholine (lyso-PC), a polar phospholipid product increased in atherogenic lipoproteins and atherosclerotic lesions, has been shown to differentially induce functional intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 and mRNA for platelet-derived growth factor (PDGF)A and B chains and heparin-binding epidermal growth factorlike growth factor in various cultured endothelial cells. In this study, we have demonstrated increased expression of cell- and matrix-associated forms of PDGFB chain (PDGF-B) protein elicited by lyso-PC and further characterized potential signal transduction mechanisms responsible for lyso-PCinduced gene expression, focusing on PDGF-B and ICAM-1 genes in cultured human umbilical vein endothelial cell models. Cycloheximide almost completely inhibited PDGF-B but not ICAM-1 mRNA induction elicited by lyso-PC, suggesting that dependence on de novo protein synthesis for PDGF-B is different from that for ICAM-1. Prolonged exposure to phorbol myristate acetate (PMA), which depletes protein kinase C (PKC), or staurosporine, a PKC inhibitor, did not block lyso-PCinduced increases in PDGF-B or ICAM-1 mRNA. Forskolin and dibutyryl cAMP, which elevate intracellular cAMP levels, blocked both PDGF-B and ICAM-1 upregulation elicited by lyso-PC; however, these cAMP-elevating agents did not suppress ICAM-1 upregulation by PMA. Taken together, PDGF-B and ICAM-1 gene induction by lyso-PC may involve different signaling mechanisms; however, both appear to be independent of PMA-regulatable PKC activation but are suppressed by increased levels of intracellular cAMP.
Key Words: protein kinase C platelet-derived growth factorB chain intercellular adhesion molecule-1 cAMP lysophosphatidylcholine
This article has been cited by other articles:
![]() |
A. Md Sheikh, H. Ochi, A. Manabe, and J. Masuda Lysophosphatidylcholine posttranscriptionally inhibits interferon-{gamma}-induced IP-10, Mig and I-Tac expression in endothelial cells Cardiovasc Res, January 1, 2005; 65(1): 263 - 271. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Morimoto, N. Kume, S. Miyamoto, Y. Ueno, H. Kataoka, M. Minami, K. Hayashida, N. Hashimoto, and T. Kita Lysophosphatidylcholine Induces Early Growth Response Factor-1 Expression and Activates the Core Promoter of PDGF-A Chain in Vascular Endothelial Cells Arterioscler. Thromb. Vasc. Biol., May 1, 2001; 21(5): 771 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yokoyama, F. Shimizu, and M. Setaka Simultaneous separation of lysophospholipids from the total lipid fraction of crude biological samples using two-dimensional thin-layer chromatography J. Lipid Res., January 1, 2000; 41(1): 142 - 147. [Abstract] [Full Text] |
||||
![]() |
E. Nishi, N. Kume, Y. Ueno, H. Ochi, H. Moriwaki, and T. Kita Lysophosphatidylcholine Enhances Cytokine-Induced Interferon Gamma Expression in Human T Lymphocytes Circ. Res., September 7, 1998; 83(5): 508 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sugiyama, K. Kugiyama, N. Ogata, H. Doi, Y. Ota, M. Ohgushi, T. Matsumura, H. Oka, and H. Yasue Biphasic Regulation of Transcription Factor Nuclear Factor-{kappa}B Activity in Human Endothelial Cells by Lysophosphatidylcholine Through Protein Kinase C–Mediated Pathway Arterioscler. Thromb. Vasc. Biol., April 1, 1998; 18(4): 568 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Wong, K. Tran, G. N. Pierce, A. C. Chan, K. O, and P. C. Choy Lysophosphatidylcholine Stimulates the Release of Arachidonic Acid in Human Endothelial Cells J. Biol. Chem., March 20, 1998; 273(12): 6830 - 6836. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hara, T. Shike, N. Takasu, and T. Mizui Lysophosphatidylcholine Promotes Cholesterol Efflux From Mouse Macrophage Foam Cells Arterioscler. Thromb. Vasc. Biol., July 1, 1997; 17(7): 1258 - 1266. [Abstract] [Full Text] |
||||
![]() |
E. Nishi, N. Kume, H. Ochi, H. Moriwaki, Y. Wakatsuki, S. Higashiyama, N. Taniguchi, and T. Kita Lysophosphatidylcholine Increases Expression of Heparin-Binding Epidermal Growth Factor–Like Growth Factor in Human T Lymphocytes Circ. Res., May 19, 1997; 80(5): 638 - 644. [Abstract] [Full Text] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |